Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
04/2007
04/11/2007EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
04/11/2007CN1944417A Five-membered-ring compound
04/10/2007US7202379 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof
04/10/2007US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202239 Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
04/10/2007CA2164276C New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
04/05/2007US20070078229 Dithiocarbamic esters
04/05/2007DE19832146B4 Verfahren zur Herstellung von 3-Methylpyrazol bzw. dessen Salze A process for preparing 3-methylpyrazole and its salts
04/05/2007DE102006029721A1 Syntheseverfahren Synthesis method
04/04/2007EP1377556B1 Pyrazole derivatives for treating hiv
04/04/2007EP1362033B1 Pyridine matrix metalloproteinase inhibitors
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007CN1308297C Phenyl sulfamate derivatives
04/03/2007US7199158 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
04/03/2007CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
04/03/2007CA2362193C Volatilizable solid phase supports for compound synthesis
04/03/2007CA2288140C Farnesyltransferase inhibiting quinazolinones
03/2007
03/28/2007EP1517906B1 Method for the production of 1,2,4-triazolylmethyl-oxiranes
03/28/2007CN1307155C Deltal-pyrrolines used as pesticides
03/28/2007CN1306935C Vasopressin antagonist and oxytocin antagonist
03/27/2007US7196229 For controlling harmful plants
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
03/21/2007EP1764366A2 Thrombin receptor antagonists
03/20/2007US7193079 Reacting 2-carboxamidoethyl-Indolecarboxylic acid compound with methyl sulfonic acid and phosphorus pentoxide, reacting resulting indoloazepine compound with phenyl oxazolone and a transition metal catalyst, reacting resulting compound with with thiourea and a base in a solvent
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007CA2278509C Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof
03/14/2007EP1762567A1 Pyrazole derivatives for treating HIV
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1304390C Novel gamma secretase inhibitors
03/14/2007CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors
03/14/2007CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals
03/13/2007US7189858 N-phenyl substituted carbamoyloxyalkyl-azolium derivatives
03/13/2007US7189738 Substituted isoindoles and their use thereof
03/13/2007CA2315227C Arylpiperazines having activity at the serotonin 1a receptor
03/07/2007CN1923818A Irreversible inhibitors of tyrosine kinases
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007CA2168319C 4-mercaptobenzoylguanidine derivatives
03/06/2007CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/06/2007CA1341521C 1-hydroxyethyl-azole derivatives, a process for their preparation and their use as plant growth regulators and fungicides
02/2007
02/28/2007EP1756097A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
02/28/2007CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation
02/27/2007US7183320 For therapy of neoplastic diseases
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/22/2007DE102006033659A1 Preparation of alpha chlorinated carbonyl compound comprises decarboxylating an alpha-chlorinated beta-ketoester compound in an aqueous medium in the presence of a base at a mild basic pH
02/21/2007EP1754703A2 N-Heterocyclic derivatives as nos inhibitors
02/21/2007EP1361851B1 Primary intermediates for oxidative coloration of hair
02/21/2007EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents
02/20/2007US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
02/20/2007US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/20/2007US7179806 Δ1-pyrrolines used as pesticides
02/15/2007US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
02/15/2007US20070037803 Benzimidazole derivatives
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/14/2007EP1752455A2 Chemokine receptor binding heterocyclic compounds
02/14/2007EP1751104A1 Synthesis methods and intermediates for the manufacture of rizatriptan
02/14/2007EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors
02/14/2007CN1914181A Method for producing ionic liquids
02/13/2007CA2531858C Nitrification inhibitors and the use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032497 Fused-ring compounds and use thereof as drugs
02/07/2007CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
02/07/2007CN1910124A Distillation of ionic liquids
02/07/2007CN1298711C Processes for producing epoxytriazole derivative and intermediate therefor
02/06/2007US7173043 Heteroaromate OSC inhibitors
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007CA2192594C Preparation of .alpha.-methoxyiminocarboxylic acid methylamides and intermediates therfore
02/01/2007US20070027322 N-substituted carbamoyloxyalkyl-azolium derivatives
02/01/2007US20070027318 Quinoline derivatives and quinazoline derivatives
01/2007
01/31/2007CN1297535C Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
01/30/2007US7169937 use for regulating the degree of polymerization during the polymerization of monomers, such as homo- or copolymerization of chloroprene and/or dichlorobutadiene
01/30/2007US7169789 Quinoline derivatives and quinazoline derivatives
01/30/2007US7169782 Aryl substituted thiazolidinones and the use thereof
01/25/2007US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals
01/25/2007US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
01/25/2007US20070021407 Substituted quinolines as antitumor agents
01/24/2007EP1472217B1 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
01/24/2007EP0968206B8 N-heterocyclic derivatives as nos inhibitors
01/23/2007US7166630 contains 4-[ alpha -hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid; prophylaxis, hypomyelination, dysmyelination or demyelination; myelin-associated glycoprotein (MAG)
01/23/2007US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES
01/23/2007US7166595 3H-Pyrimidin-4-one derivatives; antiproliferative, anticarcinogenic and antiinflammatory agents; hyperplasia, restenosis, cardiac hypertrophy, autoimmune disorders; fungicides
01/23/2007CA2192186C Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
01/18/2007US20070015819 Novel compounds
01/18/2007US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
01/18/2007US20070015762 NPY Y5 antagonist
01/17/2007EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents
01/17/2007CN1295144C Stabilized hydroxylamine solutions
01/16/2007US7163953 Benzylether derivatives
01/11/2007US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/11/2007US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer
01/11/2007US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
01/09/2007CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
01/03/2007CN1890272A Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 163